Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling

Toxicology

Volumn 265, Issue 3, 2009, Pages 87-95

  Kilk, Kalle ^a   Mahlapuu, Riina ^a   Soomets, Ursel ^a   Langel, Ülo ^a,b  

^a UNIVERSITY OF TARTU   (Estonia)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Cell penetrating peptides; Cytotoxicity; Delivery vehicles; Metabolomics; Side effects

Indexed keywords

AMPHIPATHIC PEPTIDE; CELL PENETRATING PEPTIDE; HIV TAT DERIVED PEPTIDE; NONAARGININE; PENETRATIN; PEPTIDE DERIVATIVE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; TRANSPORTAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; ENERGY; IN VITRO STUDY; METABOLOME; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; TOXICOKINETICS;

AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CELL MEMBRANE PERMEABILITY; CHO CELLS; CRICETINAE; CRICETULUS; DRUG CARRIERS; GLUTATHIONE; METABOLOMICS; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PEPTIDES; PERMEABILITY;

EID: 71749110589     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2009.09.016     Document Type: Article

References (36)

1. Amand H.L., Fant K., Norden B., and Esbjorner E.K. Stimulated endocytosis in penetratin uptake: effect of arginine and lysine. Biochem. Biophys. Res. Commun. 371 4 (2008) 621-625
2. Derossi D., Joliot A.H., Chassaing G., and Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269 14 (1994) 10444-10450
3. Duchardt F., Fotin-Mleczek M., Schwarz H., Fischer R., and Brock R. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8 7 (2007) 848-866
4. Elmquist A., and Langel U. In vitro uptake and stability study of pVEC and its all-D analog. Biol. Chem. 384 3 (2003) 387-393
5. Foerg C., Weller K.M., Rechsteiner H., Nielsen H.M., Fernandez-Carneado J., Brunisholz R., Giralt E., and Merkle H.P. Metabolic cleavage and translocation efficiency of selected cell penetrating peptides: a comparative study with epithelial cell cultures. AAPS J. 10 2 (2008) 349-359
6. Foged C., and Nielsen H.M. Cell-penetrating peptides for drug delivery across membrane barriers. Expert Opin. Drug Deliv. 5 1 (2008) 105-117
7. Fotin-Mleczek M., Welte S., Mader O., Duchardt F., Fischer R., Hufnagel H., Scheurich P., and Brock R. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization. J. Cell Sci. 118 Pt 15 (2005) 3339-3351
8. Frankel A.D., and Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55 6 (1988) 1189-1193
9. Green M., and Loewenstein P.M. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55 6 (1988) 1179-1188
10. Gump J.M., and Dowdy S.F. TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol. Med. 13 10 (2007) 443-448
11. Hällbrink M., Floren A., Elmquist A., Pooga M., Bartfai T., and Langel U. Cargo delivery kinetics of cell-penetrating peptides. Biochim. Biophys. Acta 1515 2 (2001) 101-109
12. Hansen M., Kilk K., and Langel U. Predicting cell-penetrating peptides. Adv. Drug Deliv. Rev. 60 4-5 (2008) 572-579
13. Johansson H.J., El-Andaloussi S., Holm T., Mäe M., Jänes J., Maimets T., and Langel U. Characterization of a novel cytotoxic cell-penetrating peptide derived from p14ARF protein. Mol. Ther. 16 1 (2008) 115-123
14. Joliot A., Pernelle C., Deagostini-Bazin H., and Prochiantz A. Antennapedia homeobox peptide regulates neural morphogenesis. Proc. Natl. Acad. Sci. U.S.A. 88 5 (1991) 1864-1868
15. Jones S.W., Christison R., Bundell K., Voyce C.J., Brockbank S.M., Newham P., and Lindsay M.A. Characterisation of cell-penetrating peptide-mediated peptide delivery. Br. J. Pharmacol. 145 8 (2005) 1093-1102
16. Jurecka A. Inborn errors of purine and pyrimidine metabolism. J. Inherit Metab. Dis. 32 2 (2009) 247-263
17. Kaddurah-Daouk R., Kristal B.S., and Weinshilboum R.M. Metabolomics: a global biochemical approach to drug response and disease. Annu. Rev. Pharmacol. Toxicol. 48 (2008) 653-683
18. Keun H.C., and Athersuch T.J. Application of metabonomics in drug development. Pharmacogenomics 8 7 (2007) 731-741
19. Kosuge M., Takeuchi T., Nakase I., Jones A.T., and Futaki S. Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans. Bioconjug. Chem. 19 3 (2008) 656-664
20. Kuo J.H., Jan M.S., Lin Y.L., and Lin C. Interactions between octaarginine and U-937 human macrophages: Global gene expression profiling, superoxide anion content, and cytokine production. J. Control Release (2009)
21. la Marca G., Casetta B., Malvagia S., Pasquini E., Innocenti M., Donati M.A., and Zammarchi E. Implementing tandem mass spectrometry as a routine tool for characterizing the complete purine and pyrimidine metabolic profile in urine samples. J. Mass Spectrom. 41 11 (2006) 1442-1452
22. Lamaziere A., Wolf C., Lambert O., Chassaing G., Trugnan G., and Ayala-Sanmartin J. The homeodomain derived peptide Penetratin induces curvature of fluid membrane domains. PLoS ONE 3 4 (2008) e1938
23. Lindgren M., Hällbrink M., Prochiantz A., and Langel U. Cell-penetrating peptides. Trends Pharmacol. Sci. 21 3 (2000) 99-103
24. Morris M.C., Deshayes S., Heitz F., and Divita G. Cell-penetrating peptides: from molecular mechanisms to therapeutics. Biol. Cell 100 4 (2008) 201-217
25. Moschos S.A., Jones S.W., Perry M.M., Williams A.E., Erjefalt J.S., Turner J.J., Barnes P.J., Sproat B.S., Gait M.J., and Lindsay M.A. Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. Bioconjug. Chem. 18 5 (2007) 1450-1459
26. Nakase I., Niwa M., Takeuchi T., Sonomura K., Kawabata N., Koike Y., Takehashi M., Tanaka S., Ueda K., Simpson J.C., Jones A.T., Sugiura Y., and Futaki S. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol. Ther. 10 6 (2004) 1011-1022
27. Neundorf I., Rennert R., Franke J., Kozle I., and Bergmann R. Detailed analysis concerning the biodistribution and metabolism of human calcitonin-derived cell-penetrating peptides. Bioconjug. Chem. 19 8 (2008) 1596-1603
28. Nicholson J.K., Connelly J., Lindon J.C., and Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1 2 (2002) 153-161
29. Pereira C., Santos M.S., and Oliveira C. Involvement of oxidative stress on the impairment of energy metabolism induced by A beta peptides on PC12 cells: protection by antioxidants. Neurobiol. Dis. 6 3 (1999) 209-219
30. Pooga M., Lindgren M., Hällbrink M., Brakenhielm E., and Langel U. Galanin-based peptides, galparan and transportan, with receptor-dependent and independent activities. Ann. NY Acad. Sci. 863 (1998) 450-453
31. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J., Chernomordik L.V., and Lebleu B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278 1 (2003) 585-590
32. Saar K., Lindgren M., Hansen M., Eiriksdottir E., Jiang Y., Rosenthal-Aizman K., Sassian M., and Langel U. Cell-penetrating peptides: a comparative membrane toxicity study. Anal. Biochem. 345 1 (2005) 55-65
33. Shi D.Y., Xie F.Z., Zhai C., Stern J.S., Liu Y., and Liu S.L. The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells. Mol. Cancer 8 (2009) 32
34. Vives E., Brodin P., and Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272 25 (1997) 16010-16017
35. Waldeck W., Pipkorn R., Korn B., Mueller G., Schick M., Toth K., Wiessler M., Didinger B., and Braun K. Transporter molecules influence the gene expression in HeLa cells. Int. J. Med. Sci. 6 1 (2009) 18-27
36. Wu R.P., Youngblood D.S., Hassinger J.N., Lovejoy C.E., Nelson M.H., Iversen P.L., and Moulton H.M. Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity. Nucleic Acids Res. 35 15 (2007) 5182-5191